Literature DB >> 24215811

Postmortem detection of 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine] in fluids and tissues determined by high performance liquid chromatography with tandem mass spectrometry from a traumatic death.

Justin L Poklis1, Kelly G Devers2, Elise F Arbefeville2, Julia M Pearson2, Eric Houston3, Alphonse Poklis4.   

Abstract

We present a traumatic fatality of a 19-year-old man who had ingested blotter paper containing 25I-NBOMe [2-(4-iodo-2,5-dimethoxyphenyl)-N-[(2-methoxyphenyl)methyl]ethanamine]. Postmortem specimens were analyzed by high performance liquid chromatography with tandem mass spectrometry (HPLC/MS/MS). Toxicology findings for fluids based upon blood or urine calibrators were as follows: peripheral blood, 405 pg/mL; heart blood, 410 pg/mL; urine, 2.86 ng/mL; and vitreous humor, 99 pg/mL. While findings based upon the method of standard additions were: gastric contents, 7.1 μg total; bile, 10.9 ng/g; brain, 2.54 ng/g and liver, 7.2 ng/g. To our knowledge the presented case is the first postmortem case of 25I-NBOMe intoxication documented by toxicological analysis of tissues and body fluids.
Copyright © 2013 Elsevier Ireland Ltd. All rights reserved.

Entities:  

Keywords:  25I-NBOMe; Bath salts; Designer drugs; HPLC/MS/MS

Mesh:

Substances:

Year:  2013        PMID: 24215811      PMCID: PMC3969735          DOI: 10.1016/j.forsciint.2013.10.015

Source DB:  PubMed          Journal:  Forensic Sci Int        ISSN: 0379-0738            Impact factor:   2.395


  32 in total

Review 1.  Synthetic cathinones (bath salts): legal status and patterns of abuse.

Authors:  Jennifer A Fass; Andrea D Fass; Angela S Garcia
Journal:  Ann Pharmacother       Date:  2012-02-28       Impact factor: 3.154

Review 2.  3,4-methylenedioxypyrovalerone (MDPV): chemistry, pharmacology and toxicology of a new designer drug of abuse marketed online.

Authors:  M Coppola; R Mondola
Journal:  Toxicol Lett       Date:  2011-10-08       Impact factor: 4.372

3.  Molecular interaction of serotonin 5-HT2A receptor residues Phe339(6.51) and Phe340(6.52) with superpotent N-benzyl phenethylamine agonists.

Authors:  Michael R Braden; Jason C Parrish; John C Naylor; David E Nichols
Journal:  Mol Pharmacol       Date:  2006-09-25       Impact factor: 4.436

4.  High specific activity tritium-labeled N-(2-methoxybenzyl)-2,5-dimethoxy-4-iodophenethylamine (INBMeO): a high-affinity 5-HT2A receptor-selective agonist radioligand.

Authors:  David E Nichols; Stewart P Frescas; Benjamin R Chemel; Kenneth S Rehder; Desong Zhong; Anita H Lewin
Journal:  Bioorg Med Chem       Date:  2008-04-25       Impact factor: 3.641

5.  Clinical experience with and analytical confirmation of "bath salts" and "legal highs" (synthetic cathinones) in the United States.

Authors:  Henry A Spiller; Mark L Ryan; Robert G Weston; Joanne Jansen
Journal:  Clin Toxicol (Phila)       Date:  2011-07       Impact factor: 4.467

6.  Molecular connectivity analysis of hallucinogenic mescaline analogs.

Authors:  R A Glennon; L B Kier; A T Shulgin
Journal:  J Pharm Sci       Date:  1979-07       Impact factor: 3.534

7.  Analysis of NRG 'legal highs' in the UK: identification and formation of novel cathinones.

Authors:  Simon D Brandt; Sally Freeman; Harry R Sumnall; Fiona Measham; Jon Cole
Journal:  Drug Test Anal       Date:  2010-12-29       Impact factor: 3.345

Review 8.  Pimavanserin tartrate: a 5-HT2A inverse agonist with potential for treating various neuropsychiatric disorders.

Authors:  Atheir Abbas; Bryan L Roth
Journal:  Expert Opin Pharmacother       Date:  2008-12       Impact factor: 3.889

9.  25C-NBOMe--new potent hallucinogenic substance identified on the drug market.

Authors:  Dariusz Zuba; Karolina Sekuła; Agnieszka Buczek
Journal:  Forensic Sci Int       Date:  2012-09-16       Impact factor: 2.395

10.  Postmortem tissue distribution of MDPV following lethal intoxication by "bath salts".

Authors:  John F Wyman; Eric S Lavins; David Engelhart; Erica J Armstrong; Kimberly D Snell; Paul D Boggs; Shaena M Taylor; Rindi N Norris; Frank P Miller
Journal:  J Anal Toxicol       Date:  2013-02-13       Impact factor: 3.367

View more
  14 in total

1.  "My friend said it was good LSD": a suicide attempt following analytically confirmed 25I-NBOMe ingestion.

Authors:  Joji Suzuki; Justin L Poklis; Alphonse Poklis
Journal:  J Psychoactive Drugs       Date:  2014 Nov-Dec

Review 2.  Toxicities associated with NBOMe ingestion-a novel class of potent hallucinogens: a review of the literature.

Authors:  Joji Suzuki; Michael A Dekker; Erin S Valenti; Fabiola A Arbelo Cruz; Ady M Correa; Justin L Poklis; Alphonse Poklis
Journal:  Psychosomatics       Date:  2014-11-06       Impact factor: 2.386

3.  Neurochemical pharmacology of psychoactive substituted N-benzylphenethylamines: High potency agonists at 5-HT2A receptors.

Authors:  Amy J Eshleman; Katherine M Wolfrum; John F Reed; Sunyoung O Kim; Robert A Johnson; Aaron Janowsky
Journal:  Biochem Pharmacol       Date:  2018-09-25       Impact factor: 5.858

4.  Fatalities associated with NPS stimulants in the Greater Cologne area.

Authors:  Sabrina Lehmann; Tobias Kieliba; Mario Thevis; Markus A Rothschild; Katja Mercer-Chalmers-Bender
Journal:  Int J Legal Med       Date:  2019-11-18       Impact factor: 2.686

5.  Identification of Metabolite Biomarkers of the Designer Hallucinogen 25I-NBOMe in Mouse Hepatic Microsomal Preparations and Human Urine Samples Associated with Clinical Intoxication.

Authors:  Justin L Poklis; Sara K Dempsey; Kai Liu; Joseph K Ritter; Carl Wolf; Shijun Zhang; Alphonse Poklis
Journal:  J Anal Toxicol       Date:  2015-10       Impact factor: 3.367

6.  Analysis of 25I-NBOMe, 25B-NBOMe, 25C-NBOMe and Other Dimethoxyphenyl-N-[(2-Methoxyphenyl) Methyl]Ethanamine Derivatives on Blotter Paper.

Authors:  Justin L Poklis; Stephen A Raso; Kylie N Alford; Alphonse Poklis; Michelle R Peace
Journal:  J Anal Toxicol       Date:  2015-10       Impact factor: 3.367

7.  Comparative neuropharmacology of N-(2-methoxybenzyl)-2,5-dimethoxyphenethylamine (NBOMe) hallucinogens and their 2C counterparts in male rats.

Authors:  Joshua S Elmore; Ann M Decker; Agnieszka Sulima; Kenner C Rice; John S Partilla; Bruce E Blough; Michael H Baumann
Journal:  Neuropharmacology       Date:  2018-03-01       Impact factor: 5.250

8.  High-performance liquid chromatography with tandem mass spectrometry for the determination of nine hallucinogenic 25-NBOMe designer drugs in urine specimens.

Authors:  Justin L Poklis; Deborah J Clay; Alphonse Poklis
Journal:  J Anal Toxicol       Date:  2014-02-16       Impact factor: 3.367

Review 9.  Psychedelics.

Authors:  David E Nichols
Journal:  Pharmacol Rev       Date:  2016-04       Impact factor: 25.468

10.  25CN-NBOMe Metabolites in Rat Urine, Human Liver Microsomes and C.elegans-Structure Determination and Synthesis of the Most Abundant Metabolites.

Authors:  Anna Šuláková; Jitka Nykodemová; Petr Palivec; Radek Jurok; Silvie Rimpelová; Tereza Leonhardt; Klára Šíchová; Tomáš Páleníček; Martin Kuchař
Journal:  Metabolites       Date:  2021-03-31
View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.